Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,886,540
  • Shares Outstanding, K 329,003
  • Annual Sales, $ 60,210 K
  • Annual Income, $ -514,020 K
  • 60-Month Beta -0.38
  • Price/Sales 152.67
  • Price/Cash Flow N/A
  • Price/Book 8.00

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate -0.37
  • Number of Estimates 5
  • High Estimate -0.35
  • Low Estimate -0.39
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +7.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.31 +55.62%
on 03/13/20
34.98 -14.09%
on 03/19/20
+3.89 (+14.87%)
since 02/27/20
3-Month
17.68 +69.97%
on 01/07/20
36.00 -16.53%
on 02/27/20
+10.53 (+53.94%)
since 12/27/19
52-Week
11.54 +160.40%
on 08/07/19
36.00 -16.53%
on 02/27/20
+10.78 (+55.94%)
since 03/27/19

Most Recent Stories

More News
Moderna Provides Update on the Impact of COVID-19 on Business Operations and Clinical Program Development

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today...

MRNA : 30.05 (+7.55%)
Why Is Moderna (MRNA) Up 6.8% Since Last Earnings Report?

Moderna (MRNA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MRNA : 30.05 (+7.55%)
The Zacks Analyst Blog Highlights: Moderna and Gilead Sciences

The Zacks Analyst Blog Highlights: Moderna and Gilead Sciences

GILD : 72.85 (-1.37%)
MRNA : 30.05 (+7.55%)
3 Best U.S. Stocks Immune to Coronavirus Jitters

The pandemic may be taking a toll on markets right now but this temporary phase offers investors a window to buy equities that have a record of performing better than the broader markets.

MSFT : 149.70 (-4.11%)
AMZN : 1,900.10 (-2.83%)
REGN : 449.52 (-0.61%)
MRNA : 30.05 (+7.55%)
AMD : 46.58 (-1.94%)
How To Play The W-Shaped Recovery

How To Play The W-Shaped Recovery

TSM : 46.91 (-5.94%)
SPLK : 124.76 (-3.39%)
SE : 43.93 (-3.96%)
MSFT : 149.70 (-4.11%)
MRNA : 30.05 (+7.55%)
MCD : 164.01 (-2.00%)
JPM : 91.13 (-7.12%)
HD : 190.55 (-2.39%)
GILD : 72.85 (-1.37%)
DIS : 96.40 (-8.50%)
BABA : 188.59 (-3.45%)
The Zacks Analyst Blog Highlights: Gilead Sciences, Regeneron, Sanofi, Moderna and Inovio Pharmaceuticals

The Zacks Analyst Blog Highlights: Gilead Sciences, Regeneron, Sanofi, Moderna and Inovio Pharmaceuticals

REGN : 449.52 (-0.61%)
SNY : 42.44 (-1.19%)
GILD : 72.85 (-1.37%)
MRNA : 30.05 (+7.55%)
INO : 8.32 (+16.36%)
Thinking about buying stock in Chesapeake Energy Corp, Canadian Solar, Moderna, Micron, or Tenet Healthcare?

InvestorsObserver issues critical PriceWatch Alerts for CHK, CSIQ, MRNA, MU, and THC.

CSIQ : 15.28 (-12.28%)
CHK : 0.1701 (-9.95%)
MRNA : 30.05 (+7.55%)
MU : 43.48 (-2.92%)
THC : 17.06 (-7.68%)
Novavax Rallies as Influenza Vaccine Meets All Goals in Study

Novavax's (NVAX) NanoFlu, the influenza vaccine candidate for adults aged 65 years and older, meets all the primary and secondary endpoints in late-stage study. Shares rise.

SNY : 42.44 (-1.19%)
MRNA : 30.05 (+7.55%)
NVAX : 13.05 (+2.43%)
INO : 8.32 (+16.36%)
Top 5 Drug Stocks To Stop The Coronavirus Pandemic

It is only a matter of time before this virus anxiety is a thing of the past.

REGN : 449.52 (-0.61%)
SNY : 42.44 (-1.19%)
GILD : 72.85 (-1.37%)
MRNA : 30.05 (+7.55%)
INO : 8.32 (+16.36%)
Coronavirus Drug Development Race to Boost These 4 Stocks

Fast-track approval for coronavirus drug trials is encouraging drug developers. Here are four stocks that can make the most of this phase.

REGN : 449.52 (-0.61%)
GILD : 72.85 (-1.37%)
MRNA : 30.05 (+7.55%)
ABBV : 72.67 (-1.57%)
INO : 8.32 (+16.36%)
VXRT : 1.7400 (+2.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MRNA with:

Business Summary

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA-...

See More

Key Turning Points

2nd Resistance Point 32.84
1st Resistance Point 31.44
Last Price 30.05
1st Support Level 28.30
2nd Support Level 26.56

See More

52-Week High 36.00
Last Price 30.05
Fibonacci 61.8% 26.66
Fibonacci 50% 23.77
Fibonacci 38.2% 20.88
52-Week Low 11.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar